212 related articles for article (PubMed ID: 10992460)
1. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.
Potter MR; Noben-Trauth N; Weis JH; Teuscher C; Weis JJ
Infect Immun; 2000 Oct; 68(10):5603-9. PubMed ID: 10992460
[TBL] [Abstract][Full Text] [Related]
2. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
Ma Y; Seiler KP; Eichwald EJ; Weis JH; Teuscher C; Weis JJ
Infect Immun; 1998 Jan; 66(1):161-8. PubMed ID: 9423853
[TBL] [Abstract][Full Text] [Related]
3. Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi.
Potter MR; Rittling SR; Denhardt DT; Roper RJ; Weis JH; Teuscher C; Weis JJ
Infect Immun; 2002 Mar; 70(3):1372-81. PubMed ID: 11854223
[TBL] [Abstract][Full Text] [Related]
4. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P
Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870
[TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
Anguita J; Rincón M; Samanta S; Barthold SW; Flavell RA; Fikrig E
J Infect Dis; 1998 Nov; 178(5):1512-5. PubMed ID: 9780277
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.
Glickstein L; Edelstein M; Dong JZ
Infect Immun; 2001 Jun; 69(6):3737-43. PubMed ID: 11349038
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
Anguita J; Persing DH; Rincon M; Barthold SW; Fikrig E
J Clin Invest; 1996 Feb; 97(4):1028-34. PubMed ID: 8613525
[TBL] [Abstract][Full Text] [Related]
8. Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense.
Brown JP; Zachary JF; Teuscher C; Weis JJ; Wooten RM
Infect Immun; 1999 Oct; 67(10):5142-50. PubMed ID: 10496888
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection.
Satoskar AR; Elizondo J; Monteforte GM; Stamm LM; Bluethmann H; Katavolos P; Telford SR
FEMS Microbiol Lett; 2000 Feb; 183(2):319-25. PubMed ID: 10675604
[TBL] [Abstract][Full Text] [Related]
10. Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice.
Yegutkin GG; Hytönen J; Samburski SS; Yrjänäinen H; Jalkanen S; Viljanen MK
J Immunol; 2010 May; 184(9):5112-20. PubMed ID: 20357256
[TBL] [Abstract][Full Text] [Related]
11. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
Keane-Myers A; Nickell SP
J Immunol; 1995 Aug; 155(4):2020-8. PubMed ID: 7636253
[TBL] [Abstract][Full Text] [Related]
12. The Classical Complement Pathway Is Required to Control
Zhi H; Xie J; Skare JT
Front Immunol; 2018; 9():959. PubMed ID: 29867944
[TBL] [Abstract][Full Text] [Related]
13. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
Yang L; Weis JH; Eichwald E; Kolbert CP; Persing DH; Weis JJ
Infect Immun; 1994 Feb; 62(2):492-500. PubMed ID: 8300208
[TBL] [Abstract][Full Text] [Related]
14. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.
Brown CR; Reiner SL
Infect Immun; 1999 Jul; 67(7):3329-33. PubMed ID: 10377109
[TBL] [Abstract][Full Text] [Related]
15. The DBA/1 strain is a novel mouse model for experimental Borrelia burgdorferi infection.
Campfield BT; Nolder CL; Davis A; Hirsch R; Nowalk AJ
Clin Vaccine Immunol; 2012 Oct; 19(10):1567-73. PubMed ID: 22855391
[TBL] [Abstract][Full Text] [Related]
16. Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.
Brown CR; Reiner SL
Infect Immun; 1998 May; 66(5):2065-71. PubMed ID: 9573090
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of experimental lyme arthritis in the absence of specific immunity.
Brown CR; Reiner SL
Infect Immun; 1999 Apr; 67(4):1967-73. PubMed ID: 10085044
[TBL] [Abstract][Full Text] [Related]
18. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease.
Weis JJ; McCracken BA; Ma Y; Fairbairn D; Roper RJ; Morrison TB; Weis JH; Zachary JF; Doerge RW; Teuscher C
J Immunol; 1999 Jan; 162(2):948-56. PubMed ID: 9916719
[TBL] [Abstract][Full Text] [Related]
19. Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.
Belperron AA; Liu N; Booth CJ; Bockenstedt LK
Front Cell Infect Microbiol; 2014; 4():75. PubMed ID: 24967215
[TBL] [Abstract][Full Text] [Related]
20. Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi.
Kenefick KB; Lim LC; Alder JD; Schmitz JL; Czuprynski CJ; Schell RF
J Infect Dis; 1993 May; 167(5):1086-92. PubMed ID: 8486941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
